Research output per year
Research output per year
Fingerprint
Dive into the research topics where Barbara Zellinger is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
Ruznic, E. (First author), Klebermass, M. (Co-author), Zellinger, B. (Co-author), Langer, B. (Co-author), Grambozov, B. (Co-author), Purevdorj, A. (Co-author), Karner, J. (Co-author), Gruber, G. (Co-author), Stana, M. (Co-author), Minasch, D. (Co-author), Kirchhammer, K., Steffal, C. (Co-author), Stranzl, H. (Co-author), Moosbrugger, R. (Co-author), Feurstein, P. (Co-author), Dieckmann, K. (Co-author), Zehentmayr, F. (Last author) & ALLSTAR Group, 1 Feb 2025, In: Journal of Clinical Medicine. 14, 3, 16 p., 945.Research output: Contribution to journal › Original Article › peer-review
Open Access2 Citations (Web of Science) -
377: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate in NSCLC III
Zehentmayr, F. (Last author), Grambozov, B., Ruznic, E. (First author), Stana, M., Karner, J., Gaisberger, C., Zellinger, B., Moosbrugger, R., Fastner, G., Studnicka, M. & Sedlmayer, F., 2024, In: RADIOTHERAPY AND ONCOLOGY.Research output: Contribution to journal › Abstract (Journal) › peer-review
Open Access -
118P High dose chemo-radio-immunotherapy for NSCLC III: ESR/ATS thresholds for DLCO correlate with radiation dosimetry and predict pneumonitis
Grambozov, B., Zehentmayr, F. (First author), Karner, J., Stana, M., Gaisberger, C., Fastner, G., Sedlmayer, F., Ruznic, E., Zellinger, B., Studnicka, M. & Moosbrugger, R., 2023, In: JOURNAL OF THORACIC ONCOLOGY.Research output: Contribution to journal › Abstract (Journal) › peer-review
Open Access -
Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate
Stana, M. (First author), Grambozov, B. (Co-author), Karner, J. (Co-author), Gollner, I., Gaisberger, C. (Co-author), Ruznic, E., Zellinger, B. (Co-author), Moosbrugger, R., Studnicka, M. (Co-author), Fastner, G. (Co-author), Sedlmayer, F. (Co-author) & Zehentmayr, F. (Last author), 25 Mar 2023, In: Cancers. 15, 7Research output: Contribution to journal › Original Article › peer-review
3 Citations (Web of Science) -
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3
Ruznic, E., Zellinger, B., Bodenhofer, U., Engländer, I., Kronberger, C., Grambozov, B., Stana, M., Karner, J., Fastner, G., Sotlar, K., Sedlmayer, F. & Zehentmayr, F., 2023, In: RADIOTHERAPY AND ONCOLOGY. 182, p. S1174-S1175Research output: Contribution to journal › Abstract (Journal) › peer-review
Projects
- 2 Finished
-
Mutational analysis of BRCAness genes in triple-negative breast cancer by next-generation sequencing
Zellinger, B. (PI)
1/12/18 → 1/12/19
Project: Research
-
NR2F1-ERalpha induced hsa-miR-375 promotes local relapse in breast cancer by targeting RASD1
Sedlmayer, F. (Further contributor), Zehentmayr, F. (PI), Zellinger, B. (Further contributor) & Kronberger, C. (Further contributor)
1/02/18 → 1/02/19
Project: Research